Wendy S. Johnson - Jul 8, 2021 Form 4 Insider Report for Reneo Pharmaceuticals, Inc. (RPHM)

Role
Chief Development Officer
Signature
/s/ Vineet R. Jindal, Attorney-in-Fact
Stock symbol
RPHM
Transactions as of
Jul 8, 2021
Transactions value $
$220,120
Form type
4
Date filed
7/9/2021, 06:52 PM
Previous filing
Jun 21, 2021
Next filing
Jul 15, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RPHM Common Stock Options Exercise $220K +112K $1.97 112K Jul 8, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RPHM Stock option (right to buy) Options Exercise $0 -112K -100% $0.00* 0 Jul 8, 2021 Common Stock 112K $1.97 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.